Nicotine Dependence and Vaping Cessation
University of Rzeszow is involved in clinical research focused on helping people stop using nicotine-containing electronic cigarettes and reducing dual use of vaping and tobacco cigarettes. The research interest centers on smoking cessation and vaping cessation in individuals motivated to quit.
- Electronic cigarette cessation
- Nicotine dependence
- Dual use cessation
The sponsor’s research activity in this area is aligned with behavioural and pharmacological support for stopping nicotine use.
Behavioural Support in Addiction Treatment
The clinical research landscape includes behavioural support as a key therapeutic domain, reflecting interest in non-pharmacological assistance for people attempting to discontinue vaping and smoking. This area links addiction medicine with practical cessation support.
- Behavioural intervention
- Addiction counselling
- Quit support
Research activity in this domain addresses the clinical management of nicotine-related habits through structured support.
Pharmacological Cessation Aids
Another area of interest is the use of cytisine as a cessation aid within pharmacotherapy for nicotine withdrawal and dependence. The sponsor’s work reflects attention to medication-based strategies for tobacco use disorder and vaping-related cessation.
- Cytisine
- Pharmacological cessation treatment
- Nicotine withdrawal
This therapeutic focus connects medication support with efforts to improve abstinence from nicotine products.
Abstinence and Relapse Prevention
The trial activity also points to interest in abstinence maintenance and relapse prevention for people stopping vaping or smoking. Outcomes in this field are tied to sustained cessation and long-term control of nicotine use.
- Continuous abstinence
- Relapse prevention
- Nicotine-free maintenance
This area supports clinical evaluation of interventions aimed at maintaining tobacco- and vape-free status over time.
